Literature DB >> 29305134

Severe persistent injection site reactions after subcutaneous 2'-O-methyl phosphorothioate oligonucleotide therapy for Duchenne muscular dystrophy.

Joana Domingos1, Valeria Ricotti1, Anna E Martinez2, Francesco Muntoni3.   

Abstract

Entities:  

Keywords:  Antisense oligonucleotide; Duchenne muscular dystrophy; Exon skipping; Morphea-like skin lesion; Subcutaneous injections

Mesh:

Substances:

Year:  2017        PMID: 29305134     DOI: 10.1016/j.nmd.2017.11.015

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  3 in total

1.  Injection site reactions after long-term subcutaneous delivery of drisapersen: a retrospective study.

Authors:  Niels Hilhorst; Ifigenia Spanoudi-Kitrimi; Nathalie Goemans; Marie-Anne Morren
Journal:  Eur J Pediatr       Date:  2018-11-17       Impact factor: 3.183

2.  Persistent injection site nodules from exenatide: Successful treatment with intralesional triamcinolone.

Authors:  Kayla Riswold; Valerie Flynn
Journal:  JAAD Case Rep       Date:  2018-09-18

Review 3.  Antisense-mediated splice intervention to treat human disease: the odyssey continues.

Authors:  Ianthe Pitout; Loren L Flynn; Steve D Wilton; Sue Fletcher
Journal:  F1000Res       Date:  2019-05-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.